Peethambra Ayurved Bhawan Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 07-12-2024
- Paid Up Capital ₹ 1.47 Cr
as on 07-12-2024
- Company Age 35 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.56 Cr
as on 07-12-2024
- Revenue 29288.20%
(FY 2023)
- Profit 9634.18%
(FY 2023)
- Ebitda 40924.72%
(FY 2023)
- Net Worth 99745.91%
(FY 2023)
- Total Assets 99929.65%
(FY 2023)
About Peethambra Ayurved Bhawan
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.47 Cr.
The company currently has active open charges totaling ₹1.56 Cr.
Abhinav Gaur, Anirudh Gaur, and Akshay Gaur serve as directors at the Company.
- CIN/LLPIN
U74899DL1989PLC037359
- Company No.
037359
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Aug 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Peethambra Ayurved Bhawan?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinav Gaur  | Director | 21-Jan-2004 | Current |
| Anirudh Gaur | Director | 21-Jan-2004 | Current |
| Akshay Gaur | Director | 24-Dec-2004 | Current |
Financial Performance and Corporate Structure Insights of Peethambra Ayurved Bhawan.
Peethambra Ayurved Bhawan Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29288.2% increase. The company also saw a substantial improvement in profitability, with a 9634.18% increase in profit. The company's net worth Soared by an impressive increase of 99745.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Peethambra Ayurved Bhawan?
In 2023, Peethambra Ayurved Bhawan had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chaitanya Goods Transport LlpActive 13 years 8 monthsAbhinav Gaur, Anirudh Gaur and 1 more are mutual person
- Peetambra Plantations Private LimitedActive 33 years 2 months
Abhinav Gaur, Anirudh Gaur and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Aug 2024 | ₹5.60 M | Open |
Hdfc Bank Limited Creation Date: 21 Mar 2016 | ₹1.00 Cr | Open |
How Many Employees Work at Peethambra Ayurved Bhawan?
Peethambra Ayurved Bhawan has a workforce of 26 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Peethambra Ayurved Bhawan, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Peethambra Ayurved Bhawan's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
